Conflicts of interest: To be confirmed.
Bleeding complications: therapeutic strategies in haemostasis
Article first published online: 10 JUN 2010
© 2010 The Author. Journal compilation © 2010 International Society of Blood Transfusion
ISBT Science Series
Special Issue: XXXIst International Congress of the ISBT
Volume 5, Issue n1, pages 155–160, July 2010
How to Cite
Spannagl, M. (2010), Bleeding complications: therapeutic strategies in haemostasis. ISBT Science Series, 5: 155–160. doi: 10.1111/j.1751-2824.2010.01387.x
- Issue published online: 10 JUN 2010
- Article first published online: 10 JUN 2010
Several haemostyptic agents as well as cellular and plasmatic blood products are available for treatment of bleeding complications. Selective application of these compounds according to the patient’s haemostatic disturbances is superior to standard application of cellular concentrates and fresh frozen plasma. Near-patient testing of whole blood coagulation and fibrinolysis has been suggested for goal directed therapy. Recent data show reduction of consumption of blood products using algorithms and tailored therapy.